Clinical trial
The Role of the FCRL5 Protein in the Pathophysiology of Multiple Sclerosis and Response to Treatment
NCT07788573 is registered in ClinicalTrials.gov with Université Catholique de Louvain as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of the FCRL5 Protein in the Pathophysiology of Multiple Sclerosis and Response to Treatment
- Lead sponsor
- Université Catholique de Louvain
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 31, 2026
- Completion date
- December 31, 2029
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.